Impact of Intranasal Corticosteroids in the Management of Chronic Rhinosinusitis

Authors

  • Luiz Henrique Santos Centro Universitário Maurício de Nassau
  • Miguel Isaias Lopes Silveira
  • Giulia Gabrielly de Lima
  • João Vitor Ferreira Assunção de Araújo
  • Maria Fernanda da Silva Rodrigues
  • Débora Guimarães Alves
  • Paloma de Sousa Silva
  • Vasques Vinícius de França Landim Parente
  • Paula Andréa Sampaio de Vasconcelos Carvalho
  • Fabrícia Epaminondas Pereira
  • Rafaela Lúcio Moraes de Almeida
  • Raphael Dalla Paula Lopes
  • Maria Laura Santos Martins
  • Mariana Fabrícia Mendes Cavalcante
  • José Marcos Alves Soares da Silva
  • Thayse Velez Belmont de Brito
  • Nilber Acioli de Almeida Junior
  • Clara Beatriz Cesário de Oliveira
  • Amanda Ramalho Rocha

DOI:

https://doi.org/10.36557/2674-8169.2024v6n8p3674-3682

Keywords:

Corticosteroids; Rhinosinusitis; Treatment.

Abstract

This article reviews the medical literature on the efficacy of intranasal and topical corticosteroids in the treatment of chronic rhinosinusitis. The search was conducted on PubMed using the descriptors “Nasal Corticosteroids”, “Topical Corticosteroids”, “Chronic Rhinosinusitis”, and “Treatment”. The analysis revealed that preoperative systemic corticosteroid administration is effective in reducing eosinophilic inflammation and improving surgical planning, while topical corticosteroids showed benefits in olfactory function and reduction of symptoms and polyp size. Additionally, combined approaches and new alternatives, such as mepolizumab, have demonstrated additional benefits and improved treatment adherence, highlighting the need for integrated strategies in managing refractory chronic rhinosinusitis.

Downloads

Download data is not yet available.

References

AKIYAMA, K. et al. Impact of preoperative systemic corticosteroids on the histology and diagnosis of eosinophilic chronic rhinosinusitis. *International Archives of Allergy and Immunology*, v. 179, n. 1, p. 1-8, 2019. PMID: 30799396. Clinical Trial.

BANGLAWALA, S. M. et al. Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis. *International Forum of Allergy & Rhinology*, 2023.

BOGNANNI, A. et al. Topical corticosteroids for chronic rhinosinusitis with nasal polyposis: GRADE systematic review and network meta-analysis. *Journal of Allergy and Clinical Immunology*, v. 149, n. 5, p. 1615-1627, 2022. PMID: 35970310.

BORISH, L. et al. Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps. *Annals of Allergy, Asthma & Immunology*, v. 129, n. 4, p. 408-413, 2022. PMID: 35398492. Review.

CANTONE, E. et al. Effect of sodium hyaluronate added to topical corticosteroids in chronic rhinosinusitis with nasal polyposis. *American Journal of Rhinology & Allergy*, v. 30, n. 3, p. 165-170, 2016. PMID: 27302143.

CHUPP, G. et al. Mepolizumab reduces systemic corticosteroid use in chronic rhinosinusitis with nasal polyps. *Journal of Allergy and Clinical Immunology: Practice*, v. 11, n. 1, p. 111-120, 2023. PMID: 37586475. Clinical Trial.

FENG, S. et al. Effects of mobile phone WeChat services improve adherence to corticosteroid nasal spray treatment for chronic rhinosinusitis after functional endoscopic sinus surgery: a 3-month follow-up study. *European Archives of Oto-Rhino-Laryngology*, v. 274, n. 7, p. 2567-2573, 2017. PMID: 27822702. Clinical Trial.

FU, Z. et al. The impact of postoperative topical corticosteroid irrigation on short-term efficacy and olfactory function in patients with chronic rhinosinusitis with nasal polyps following endoscopic sinus surgery. *Minerva Medica*, v. 114, n. 2, p. 123-130, 2023. PMID: 37947783.

HEAD, K. et al. Short-course oral steroids alone for chronic rhinosinusitis. *Cochrane Database of Systematic Reviews*, v. 2016, n. 2, p. CD008659, 2016. PMID: 27113367. Review.

IKEDA, K. et al. Postoperative management of eosinophilic chronic rhinosinusitis with nasal polyps: impact of high-dose corticosteroid nasal spray. *International Archives of Otorhinolaryngology*, v. 23, n. 2, p. 184-190, 2019. PMID: 30647792.

LEUNG, R. M. et al. Should oral corticosteroids be used in medical therapy for chronic rhinosinusitis? A risk analysis. *Laryngoscope*, v. 131, n. 6, p. 1282-1287, 2021. PMID: 32633822.

LIU, C. M. et al. Impact of saline irrigation and topical corticosteroids on the postsurgical sinonasal microbiota. *International Forum of Allergy & Rhinology*, v. 5, n. 6, p. 548-554, 2015. PMID: 25556553.

PARIKH, A. et al. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. *Rhinology*, v. 39, n. 2, p. 92-96, 2001. PMID: 11486442. Clinical Trial.

SMITH, K. A. et al. Impact of continued medical therapy in patients with refractory chronic rhinosinusitis. *International Forum of Allergy & Rhinology*, v. 4, n. 5, p. 393-398, 2014. PMID: 24166890.

SNIDVONGS, K. et al. Topical steroid for chronic rhinosinusitis without polyps. *Cochrane Database of Systematic Reviews*, v. 2011, n. 6, p. CD009760, 2011. PMID: 21833974. Updated. Review.

Published

2024-08-22

How to Cite

Santos, L. H., Silveira, M. I. L., Lima, G. G. de, Araújo, J. V. F. A. de, Maria Fernanda da Silva Rodrigues, Alves, D. G., Silva, P. de S., Parente, V. V. de F. L., Carvalho, P. A. S. de V., Pereira, F. E., de Almeida, R. L. M., Lopes, R. D. P., Santos Martins, M. L., Cavalcante, M. F. M., da Silva, J. M. A. S., Brito, T. V. B. de, Almeida Junior, N. A. de, Oliveira, C. B. C. de, & Rocha, A. R. (2024). Impact of Intranasal Corticosteroids in the Management of Chronic Rhinosinusitis. Brazilian Journal of Implantology and Health Sciences, 6(8), 3674–3682. https://doi.org/10.36557/2674-8169.2024v6n8p3674-3682